uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer
Show others and affiliations
2004 (English)In: European Journal of Surgical Oncology, ISSN 0748-7983, E-ISSN 1532-2157, Vol. 30, no 5, 495-500 p.Article in journal (Refereed) Published
Abstract [en]

AIMS: We investigated the association between preoperative serum levels of follicle stimulating hormone (FSH) and the prognosis in women with invasive breast cancer. METHODS: Serum levels of FSH were measured in 182 premenopausal and 581 peri- or postmenopausal women with invasive breast cancer. They were followed for a mean time of 84 months. The study endpoint was death from breast cancer (182 events). Analyses were stratified on menopausal status. RESULTS: None of the estimates showed a statistically significant result. In both pre- and postmenopausal women there was a nominally higher probability of survival with a higher FSH level. Point estimates in multivariate analysis incorporating age, tumour diameter, axillary lymph status, estrogen and progesterone receptor content and year of treatment indicated a stronger association with FSH levels in premenopausal than postmenopausal women (relative hazard 0.63 or 0.85, respectively in the highest compared with the lowest quartile). CONCLUSION: We did not find any statistically significant association between preoperative serum level of FSH and prognosis. Today, FSH is not a clinical target for intervention or a clinically useful prognostic factor and the results of clinical studies up to date can only be used for motivation of further experimental laboratory research.

Place, publisher, year, edition, pages
2004. Vol. 30, no 5, 495-500 p.
Keyword [en]
Adult, Aged, Breast Neoplasms/*blood/*diagnosis/epidemiology, Comparative Study, Female, Follicle Stimulating Hormone/*blood, Follow-Up Studies, Humans, Middle Aged, Multivariate Analysis, Neoplasm Staging, Postmenopause/blood, Premenopause/blood, Preoperative Care, Prognosis, Prospective Studies, Risk Factors, Statistics, Survival Analysis, Sweden/epidemiology, Tumor Markers; Biological/*blood, Women's Health
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-70031DOI: 10.1016/j.ejso.2004.01.018PubMedID: 15135476OAI: oai:DiVA.org:uu-70031DiVA: diva2:97942
Available from: 2005-04-14 Created: 2005-04-14 Last updated: 2017-11-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15135476&dopt=Citation

Authority records BETA

Holmberg, Lars

Search in DiVA

By author/editor
Holmberg, Lars
By organisation
Department of Surgical Sciences
In the same journal
European Journal of Surgical Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 351 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf